StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$33.39−0.68 (-2.00%)

Close on Nov 19, 2026Market cap $2.20BP/E 6.2Yield –

Lakefront Biotherapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 66M, up 0.0% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is 66M in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202566M0.0%
FY2024Dec 31, 202466M+0.0%
FY2023Dec 31, 202366M+0.3%
FY2022Dec 31, 202266M+0.3%
FY2021Dec 31, 202166M+0.7%
FY2020Dec 31, 202065M+12.9%
FY2019Dec 31, 201958M+10.6%
FY2018Dec 31, 201852M+5.3%
FY2017Dec 31, 201749M+4.6%
FY2016Dec 31, 201647M+32.5%
FY2015Dec 31, 201536M–

More Lakefront Biotherapeutics figures

See a number that looks wrong?